Prime Medicine PRME
NASDAQ PRME
$3.81 -0.11 (-2.81%)
At close: Oct 21, 2026 · 4:00 PM EDT

Prime Medicine (PRME) Non-Current Deferred Tax Liability (2021 - 2024)

Updated

Prime Medicine's Non-Current Deferred Tax Liability came in at $134,000 for Q1 2024, up 74.0% from $77,000 a year earlier.

Analysis

Prime Medicine (PRME) Non-Current Deferred Tax Liability (2021 - 2024) Analysis & Trends

At the end of FY2022, Prime Medicine's Non-Current Deferred Tax Liability was $279,000, down 77.6% from FY2021.

  • Going back by year, Non-Current Deferred Tax Liability was $1.24 million in FY2021.
  • The Q1 2024 figure represents the highest quarterly Non-Current Deferred Tax Liability since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Prime Medicine 677.89 Mn 56.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 134,000.00
Jun 30, 2023 108,000.00
Mar 31, 2023 77,000.00
Dec 31, 2022 279,000.00
Sep 30, 2022 481,000.00
Dec 31, 2021 1.24 Mn
API Access

Prime Medicine Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=PRME&period=max&api_key=YOUR_API_KEY